Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4525611

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
[N-]=[N+]=NC[C@@H]1[C@@H](O)[C@@H](O)[C@@]2(n3cc(I)c4c(N)ncnc43)C[C@@H]12

Basic Information

ChEMBL ID CHEMBL4525611
Phase Preclinical
Structure Type MOL
InChI Key KQMITLMWPOBFHU-KTCMLSIRSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

427.2
MW (Da)
1.00
ALogP
7
HBA
3
HBD
145.9
PSA (Ų)
0.29
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C13H14IN7O2
MW 427.21
Aromatic Rings 2
Heavy Atoms 23
NP-Likeness 0.73

Activity Summary

IC50 1 meas. best 5.27

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Adenosine kinase
CHEMBL3589
IC50 5.27 5.27 5380.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Adenosine kinase IC50 = 5380.0 nM 5.27 Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-... 27410258

Literature References

PubMed DOI Target Context # Activities
27410258 10.1021/acs.jmedchem.6b00689 Adenosine kinase 5

Data from ChEMBL 36 via Core Engine